Bing

SEARCH HISTORY

AMAG Pharmaceuticals (NASDAQ:AMAG) CEO William K. Heiden sold 20,000 shares of the stock in a transaction that occurred on Wednesday, July 15th. The stock was sold at an average price of $75.00, for a total value of $1,500,000.00. Following the …
Mideast Times · 7/19/2015
AMAG) have been given a consensus rating of “Buy” by the nine analysts that are currently covering the company, ARN reports. Three investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a ...
sleekmoney.com · 7/16/2015
Cytori Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%. A better-ranked biomedical stock is AMAG Pharmaceuticals, Inc. (AMAG) with a Zacks Rank #1 (Strong Buy). Is CYTX going up? Or down? Predict to see what …
Yahoo Finance · 3 hours ago
Cytori Therapeutics
More from Bing News
The company’s quarterly revenue was up 399.5% on a year-over-year basis. Several analysts have recently commented on the stock. Analysts at Zacks upgraded shares of AMAG Pharmaceuticals from a “hold” rating to a “strong-buy” rating and set …
Ticker Report · 7/23/2015
Cytori Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%. A better-ranked biomedical stock is AMAG Pharmaceuticals, Inc. (AMAG - Snapshot Report) with a Zacks Rank #1 (Strong Buy). Want the latest recommendations …
ZACKS · 5 hours ago
Stock Moves
Mannkind Corp (MNKD): MNKD stock is down 6.3%, marking the third consecutive day the stock has decreased. Amag Pharmaceuticals (AMAG): AMAG stock is down 5.4%, marking the seventh consecutive day the stock has decreased. Cempra Inc …
Investor Place · 1 day ago
Healthcare Stocks
AMAG Pharmaceuticals shares have climbed 70 percent since the beginning of the year. The stock has more than tripled in the last 12 months. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks …
CNBC · 7/23/2015
There is potential upside of 0.2% for shares of AMAG Pharmaceuticals based on a current price of $66.61 and an average consensus analyst price target of $66.75. The stock should hit resistance at its 50-day moving average (MA) of $69.69, as well as …
Financial News Network Online · ByRobert Cotter · 7/27/2015
AMAG Pharmaceuticals
have a significant and adverse impact on AMAG's stock price. AMAG cautions you not to place undue reliance on any forward-looking statements, which speak only as of the date they are made. AMAG disclaims any obligation to publicly update or revise …
GlobeNewswire · 7/23/2015
quarter
In addition to specific proprietary factors, Trade-Ideas identified AMAG Pharmaceuticals as such a stock due to the following factors: AMAG has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $46.9 million.
The Street · 7/15/2015